Papers
6
Total Citations
273
H-Index
5
About
Kristine Zanotti is a distinguished gynecologic oncologist whose research sits at the intersection of minimally invasive surgery, robotic-assisted techniques, and advanced radiotherapy for gynecologic malignancies. Her work has made significant contributions to improving surgical and treatment outcomes for women with endometrial cancer, endometriosis, and recurrent gynecologic cancers. Zanotti's most influential contribution, garnering 109 citations, demonstrated the safety and efficacy of minimally invasive surgery compared to traditional laparotomy in high-grade endometrial cancer patients treated at high-volume cancer centers — work that has helped shift clinical practice toward less morbid surgical approaches. Equally impactful is her pioneering phase II trial of robotic stereotactic body radiosurgery (SBRT) for metastatic gynecologic cancers (103 citations), which established ablative radiotherapy as a viable, lower-morbidity option for a particularly difficult-to-treat patient population. She further advanced this work through a phase I trial combining carboplatin-gemcitabine chemotherapy with stereotactic ablative radiotherapy in recurrent disease. Beyond oncology, Zanotti has investigated robotic-assisted hysterectomy for severe endometriosis and refined understanding of surgical anatomy relevant to port placement. Her body of work reflects a consistent commitment to optimizing both surgical precision and patient safety across gynecologic care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6